Find all School-related info fast with the new School-Specific MBA Forum

It is currently 24 Jul 2016, 17:45
GMAT Club Tests

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

With the emergence of biotechnology companies, it was feared

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

VP
VP
User avatar
Joined: 18 May 2008
Posts: 1287
Followers: 14

Kudos [?]: 327 [0], given: 0

With the emergence of biotechnology companies, it was feared [#permalink]

Show Tags

New post 03 Jun 2008, 00:21
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 0% (00:00) wrong based on 1 sessions

HideShow timer Statistics

With the emergence of biotechnology companies, it was feared that they would impose silence about
proprietary results on their in–house researchers and their academic consultants. This constraint, in turn, would
slow the development of biological science and engineering.
Which of the following, if true, would tend to weaken most seriously the prediction of scientific secrecy described
above?
A. Biotechnological research funded by industry has reached some conclusions that are of major scientific
importance.
B. When the results of scientific research are kept secret, independent researchers are unable to build on
those results.
C. Since the research priorities of biotechnology companies are not the same as those of academic institutions,
the financial support of research by such companies distorts the research agenda.
D. To enhance the companies’ standing in the scientific community, the biotechnology companies encourage
employees to publish their results, especially results that are important.
E. Biotechnology companies devote some of their research resources to problems that are of fundamental
scientific importance and that are not expected to produce immediate practical applications.
Senior Manager
Senior Manager
User avatar
Joined: 14 Mar 2007
Posts: 317
Location: Hungary
Followers: 2

Kudos [?]: 23 [0], given: 3

Re: CR [#permalink]

Show Tags

New post 03 Jun 2008, 00:56
D is the answer.

the biotechnology companies encourage
employees to publish their results, especially results that are important.

Therfore, information will not be hidden.
Director
Director
User avatar
Joined: 18 Feb 2008
Posts: 798
Followers: 21

Kudos [?]: 115 [0], given: 25

Re: CR [#permalink]

Show Tags

New post 03 Jun 2008, 00:58
D

no hidden secrets.
CEO
CEO
User avatar
Joined: 29 Mar 2007
Posts: 2583
Followers: 19

Kudos [?]: 356 [0], given: 0

Re: CR [#permalink]

Show Tags

New post 03 Jun 2008, 08:32
ritula wrote:
With the emergence of biotechnology companies, it was feared that they would impose silence about
proprietary results on their in–house researchers and their academic consultants. This constraint, in turn, would
slow the development of biological science and engineering.
Which of the following, if true, would tend to weaken most seriously the prediction of scientific secrecy described
above?
A. Biotechnological research funded by industry has reached some conclusions that are of major scientific
importance.
B. When the results of scientific research are kept secret, independent researchers are unable to build on
those results.
C. Since the research priorities of biotechnology companies are not the same as those of academic institutions,
the financial support of research by such companies distorts the research agenda.
D. To enhance the companies’ standing in the scientific community, the biotechnology companies encourage
employees to publish their results, especially results that are important.
E. Biotechnology companies devote some of their research resources to problems that are of fundamental
scientific importance and that are not expected to produce immediate practical applications.


D.

b/c the company wants to enchance its public standing by encouriging Employees to publish results, this weakens.
Manager
Manager
User avatar
Joined: 20 Mar 2008
Posts: 159
Location: USA
Followers: 2

Kudos [?]: 40 [0], given: 0

Re: CR [#permalink]

Show Tags

New post 03 Jun 2008, 08:49
The argument
"...they would impose silence about proprietary results on their in–house researchers ..", needs to be weakened.

The perfect solution is right there in D.

D. To enhance the companies’ standing in the scientific community, the biotechnology companies encourage employees to publish their results, especially results that are important.
Re: CR   [#permalink] 03 Jun 2008, 08:49
    Similar topics Author Replies Last post
Similar
Topics:
1 Due to significant advances in biotechnology, experts agdimple333 6 13 Jun 2011, 11:23
1 With Emergence of Biotechnology Companies, it was feared Zatarra 4 28 Dec 2010, 07:37
2 With Emergence of Biotechnology Companies, it was feared amod243 8 04 Sep 2010, 13:13
2 Economist: On average, the emergency treatment for an sondenso 9 06 May 2008, 18:45
Biotechnology companies say that voluntary guideline for jyotsnasarabu 8 24 Nov 2006, 12:28
Display posts from previous: Sort by

With the emergence of biotechnology companies, it was feared

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.